Moreover, AQPs showed critical prognostic events in gastric cancer patients with different clinicopathological features such as Laurens classification, gender, pathological grade, clinical stage, HER2 status, and different choices of treatments. This evidence concerns the gene ERBB2 and gastric cancer.